Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
15.81
+0.07 (0.44%)
Sep 15, 2025, 10:35 AM EDT - Market open
Zymeworks Market Cap
Zymeworks has a market cap or net worth of $1.19 billion as of September 15, 2025. Its market cap has increased by 44.57% in one year.
Market Cap
1.19B
Enterprise Value
875.18M
1-Year Change
44.57%
Ranking
Category
Stock Price
$15.81
Market Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $1.19B, an increase of 260.77%. That is a compound annual growth rate of 16.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 1.18B | 17.32% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
| Apr 28, 2017 | 329.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |